Notes
atrial fibrillation, chronic kidney disease, chronic obstructive pulmonary disease, dementia, hypertension, neuropathic pain, osteoarthritis, rheumatoid arthritis, and secondary prevention after myocardial infarction
References
Dumbreck S, et al. Drug-disease and drug-drug interactions: systematic examination of recommendations in 12 UK national clinical guidelines. BMJ 2015: h949, No. 350, 11 Mar 2015. Available from: URL: http://dx.doi.org/10.1136/bmj.h949.
Marengoni A, et al. Guidelines, polypharmacy, and drug-drug interactions in patients with multimorbidity. BMJ 2015: h1059, No. 350, 11 Mar 2015. Available from: URL: http://dx.doi.org/10.1136/bmj.h1059.
Rights and permissions
About this article
Cite this article
Drug interactions between drugs recommended in NICE guidelines. PharmacoEcon Outcomes News 724, 7 (2015). https://doi.org/10.1007/s40274-015-1985-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-015-1985-1